Schematic Depiction Of The Liposome (Image 01)
Amphotericin B Liposome Injection, Powder, Lyophilized, For Suspension
Product Images NDC 67457-926
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amphotericin B Liposome (NDC 67457-926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure Of Amphotericin B (Image 02)
Figure 1 Renal Function In Adult Patients (Image 03)
Figure 2 Average Serum Creatinine Concentrations (Image 04)
This text presents information on Mean Creatinine Concentration in mg/dL for patients with pretreatment values greater than 1.7 mg/dL and for all episodes over time. The data is shown on a graph with days of testing on the x-axis and the creatinine concentration on the y-axis.*
Amphotericin B Liposome For Injection 50 mg/vial Carton Label (Image 05)
This is a detailed description of a medication called Amphotericin B Liposome for Injection. It must be reconstituted and further diluted for intravenous infusion only. The text provides information on the composition of the product, storage instructions, dosage recommendations, and manufacturer details. Additionally, it states that this medication is not interchangeable on a mg per mg basis with other Amphotericin products. The description also includes the National Drug Code (NDC) for the product and mentions that it is manufactured for Mylan Institutional LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
